Tag Archives: U.S.

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

U.S. judge partially blocks Trump administration birth control rules

(Reuters) – A judge in California on Sunday partially blocked a set of Trump administration rules that allow employers to opt out of providing health insurance that covers women’s birth control from taking effect. U.S. District Judge Haywood Gilliam in Oakland granted a request by 14 Democratic attorneys general for a preliminary injunction. The rules,… Read More »